Nov 07, 2022 / 09:30PM GMT
Operator
Good day, and thank you for standing by. Welcome to the Xencor Q3 2022 Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Charles Liles. Please go ahead.
Charles Liles - Xencor, Inc. - Associate Director and Head of Corporate Communications & IR
Thank you, and good afternoon. Earlier today, we issued 2 press releases, which outlined the topics we plan to discuss today. The press releases are available at www.xencor.com.
With me on the call are Bassil Dahiyat, President and Chief Executive Officer; John Desjarlais, Chief Scientific Officer; John Kuch, Chief Financial Officer; and Allen Yang, Chief Medical Officer; Ralph Zitnik, Executive Medical Director and Head of Autoimmune, will join us for Q&A.
On our agenda, we will first review recent business news and financial results, followed by the presentation of results from the Phase I single
Q3 2022 Xencor Inc Earnings Call Transcript
Nov 08, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers